相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
Yanan Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Inhibition of TBK1 attenuates radiation-induced epithelial-mesenchymal transition of A549 human lung cancer cells via activation of GSK-3β and repression of ZEB1
Wen Liu et al.
LABORATORY INVESTIGATION (2014)
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Maria Angelica Cortez et al.
MOLECULAR THERAPY (2014)
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CH K1
Peijing Zhang et al.
NATURE CELL BIOLOGY (2014)
Acquired resistance to TKIs in solid tumours: learning from lung cancer
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer
Daisuke Matsubara et al.
PATHOLOGY INTERNATIONAL (2014)
Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
Peter Bronsert et al.
SURGERY (2014)
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Peijing Zhang et al.
NATURE COMMUNICATIONS (2014)
miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
Dahu Chen et al.
PLOS GENETICS (2014)
Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies
Hua Sui et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L. Chaffer et al.
CELL (2013)
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
Florian A. Siebzehnrubl et al.
EMBO MOLECULAR MEDICINE (2013)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Jeff H. Tsai et al.
GENES & DEVELOPMENT (2013)
Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line
Jin Ren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma
Jiaxing Zhang et al.
MOLECULAR BIOLOGY REPORTS (2013)
Discovery of the cancer stem cell related determinants of radioresistance
Claudia Peitzsch et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma
Yan-Ming Zhou et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
MicroRNA control of epithelial-mesenchymal transition and metastasis
Jinsong Zhang et al.
CANCER AND METASTASIS REVIEWS (2012)
Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
Jeff H. Tsai et al.
CANCER CELL (2012)
Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition
Ulf D. Kahlert et al.
CANCER LETTERS (2012)
Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo
Yi Liu et al.
CANCER SCIENCE (2012)
Clinical significance of zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer
Yoshinaga Okugawa et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma
Aidong Shen et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma
Baoqing Jia et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
K. Horiguchi et al.
ONCOGENE (2012)
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Bhuvanesh Dave et al.
BREAST CANCER RESEARCH (2012)
Pancreatic cancer: understanding and overcoming chemoresistance
Zhiwei Wang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
E. Sanchez-Tillo et al.
ONCOGENE (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines
Yasmine Haddad et al.
CLINICAL CANCER RESEARCH (2009)
miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Liana Adam et al.
CLINICAL CANCER RESEARCH (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer
Simone Spaderna et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Zeb1 links epithelial-mesenchymal transition and cellular senescence
Yongqing Liu et al.
DEVELOPMENT (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of the ZEB1 (δEF1) transcription factor in human: additional insights
Elaine M. Hurt et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Zeb1 mutant mice as a model of posterior corneal dystrophy
Yongqing Liu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Exploring the role of cancer stem cells in radioresistance
Michael Baumann et al.
NATURE REVIEWS CANCER (2008)
The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
K. Aigner et al.
ONCOGENE (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells:: potential involvement of ZEB-1 and ZEB-2
H. L. Chua et al.
ONCOGENE (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
Patrick W. B. Derksen et al.
CANCER CELL (2006)
Cyclooxygenase-2-dependent regulation of E-cadherin:: Prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer
Mariam Dohadwala et al.
CANCER RESEARCH (2006)
The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers
NS Spoelstra et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B
B Krishnamachary et al.
CANCER RESEARCH (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
A Eger et al.
ONCOGENE (2005)
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
U Cavallaro et al.
NATURE REVIEWS CANCER (2004)
Opposing functions of ZEB proteins in the regulation of the TGFβ/BMP signaling pathway
AA Postigo
EMBO JOURNAL (2003)
Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins
AA Postigo et al.
EMBO JOURNAL (2003)
Coordinated histone modifications mediated by a CtBP co-repressor complex
YJ Shi et al.
NATURE (2003)
Cell adhesion proteins as tumor suppressors
T Okegawa et al.
JOURNAL OF UROLOGY (2002)
分享论文
